Abstract:Background: Pancreatic cancer (PC) is a lethal malignancy that ranks seventh in terms of global cancer-related mortality. Despite advancements in treatment, the five-year survival rate remains low, emphasizing the urgent need for reliable early detection methods. MicroRNAs (miRNAs), a group of non-coding RNAs involved in critical gene regulatory mechanisms, have garnered significant attention as potential diagnostic and prognostic biomarkers for pancreatic cancer (PC). Their suitability stems from their accessibility and stability in blood, making them particularly appealing for clinical applications. Methods: In this study, we analyzed serum miRNA expression profiles from three independent PC datasets obtained from the Gene Expression Omnibus (GEO) database. To identify serum miRNAs associated with PC incidence, we employed three machine learning algorithms: Support Vector Machine-Recursive Feature Elimination (SVM-RFE), Least Absolute Shrinkage and Selection Operator (LASSO), and Random Forest. We developed an artificial neural network model to assess the accuracy of the identified PC-related serum miRNAs (PCRSMs) and create a nomogram. These findings were further validated through qPCR experiments. Additionally, patient samples with PC were classified using the consensus clustering method. Results: Our analysis revealed three PCRSMs, namely hsa-miR-4648, hsa-miR-125b-1-3p, and hsa-miR-3201, using the three machine learning algorithms. The artificial neural network model demonstrated high accuracy in distinguishing between normal and pancreatic cancer samples, with verification and training groups exhibiting AUC values of 0.935 and 0.926, respectively. We also utilized the consensus clustering method to classify PC samples into two optimal subtypes. Furthermore, our investigation into the expression of PCRSMs unveiled a significant negative correlation between the expression of hsa-miR-125b-1-3p and age. Conclusion: Our study introduces a novel artificial neural network model for early diagnosis of pancreatic cancer, carrying significant clinical implications. Furthermore, our findings provide valuable insights into the pathogenesis of pancreatic cancer and offer potential avenues for drug screening, personalized treatment, and immunotherapy against this lethal disease.

Pancreatic Cancer Biomarker Detection Using Recursive Feature Elimination Based On Support Vector Machine And Large Margin Distribution Machine

Pancreatic Cancer Biomarker Detection by Two Support Vector Strategies for Recursive Feature Elimination.

Identification of potential biomarkers with colorectal cancer based on bioinformatics analysis and machine learning

Early Diagnosis of Pancreatic Ductal Adenocarcinoma by Combining Relative Expression Orderings with Machine-Learning Method

Diagnostic Plasma Small Extracellular Vesicles Mirna Signatures for Pancreatic Cancer Using Machine Learning Methods

Screening of genes characteristic of pancreatic cancer by LASSO regression combined with support vector machine and recursive feature elimination, and immune correlation analysis

Proposing new early detection indicators for pancreatic cancer: Combining machine learning and neural networks for serum miRNAbased diagnostic model

LASSO regression combined with SVM-REF to screen the characteristic genes of pancreatic cancer and its immune correlation analysis

Machine Learning and Bioinformatics Analysis for Laboratory Data in Pan‐Cancers Detection

Data privacy-aware machine learning approach in pancreatic cancer diagnosis

An Efficient Feature Selection Strategy Based on Multiple Support Vector Machine Technology with Gene Expression Data

Prognostic Biomarker Identification for Pancreatic Cancer by Analyzing Multiple mRNA Microarray and microRNA Expression Datasets

Prediction Of Pancreatic Cancer By Serum Biomarkers Using Surface-Enhanced Laser Desorption/Ionization-Based Decision Tree Classifi Cation

Machine learning Algorithms and Biomarkers Identification for Pancreatic cancer Diagnosis Using Multi-Omics Data Integration

Excavation of gene markers associated with pancreatic ductal adenocarcinoma based on interrelationships of gene expression

Development of a diagnostic model for pancreatic ductal adenocarcinoma using machine learning and blood-based miRNAs

A novel method for detection of pancreatic Ductal Adenocarcinoma using explainable machine learning

Association of Radiomic Imaging Features and Gene Expression Profile As Prognostic Factors in Pancreatic Ductal Adenocarcinoma.

A Gene Signature for Breast Cancer Prognosis Using Support Vector Machine

Robust and consistent biomarker candidates identification by a machine learning approach applied to pancreatic ductal adenocarcinoma metastasis

Diagnostic ability of deep learning in detection of pancreatic tumour